<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00365118</url>
  </required_header>
  <id_info>
    <org_study_id>KF-01-278867</org_study_id>
    <nct_id>NCT00365118</nct_id>
  </id_info>
  <brief_title>Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of the trial is to compare efficacy and adverse effects of pulsed dye laser and
      intense pulsed light in patients with port wine stains.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <condition>Port-Wine Stain</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed dye laser (Candela), Intense pulsed light (Palomar)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with previously untreated and previously laser-treated naevus flammeus.
             Naevus flammeus measuring at least 5 x 7 cm within a single anatomical area. For
             example, the face corresponding to dermatomes V1, V2 and V3, back, abdomen, arms and
             legs.Patients aged two or above.Patients with skin types I-III.

        Exclusion Criteria:

          -  Patients below two years of age.

          -  Pregnant or breastfeeding patients.

          -  Patients with known increased sensitivity to visible light.

          -  Patients with a tendency to produce hypertrophic scars or celoids.

          -  Patients with skin types IV, V and VI.

          -  Patients who are clearly pigmented following recent exposure to the sun or a solarium.

          -  Patients treated with Roaccutane during the last six months.

          -  Patients who are not considered able to follow the treatment protocol (e.g. severely
             alcoholic patients, dementia patients, mentally ill patients, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Merete HÃ¦dersdal, MD, PhD, DrMedSci</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen nv</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 15, 2006</study_first_submitted>
  <study_first_submitted_qc>August 16, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2006</study_first_posted>
  <last_update_submitted>June 2, 2008</last_update_submitted>
  <last_update_submitted_qc>June 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2008</last_update_posted>
  <keyword>Port wine stains</keyword>
  <keyword>naevus flammeus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Port-Wine Stain</mesh_term>
    <mesh_term>Hemangioma, Capillary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

